Table 4.

Survivorship care discussions stratified by reported ideal doctor for follow-up care

	Ideal doctor for cancer follow-up
	Cancer specialist		Primary care		P-value
	N=191	Col %	N=29	Col %
Discussed late or long-term side effects					0.963
Yes, discussed in detail	72	(37.7)	10	(34.5)
Yes, discussed somewhat	81	(42.4)	14	(48.3)
No, did not discuss at all	31	(16.2)	5	(17.2)
Don’t know	7	(3.7)	0	0.0
Received treatment summary					0.483
No	64	(34.2)	11	(37.9)
If no, would like to have received written summary					0.718
Yes	47	(73.4)	8	(72.7)
No	14	(21.9)	3	(27.3)
Not sure	3	(4.7)	0	0.0
Yes	83	(44.4)	12	(41.4)
If yes, can find it easily					0.23
Yes	75	(90.4)	11	(91.7)
No	6	(7.2)	0	0.0
Not sure	2	(2.4)	1	(8.3)
Not sure	40	(21.4)	6	(20.7)
Received written follow-up plan at end of treatment					0.922
Yes	145	(76.7)	21	(72.4)
No	30	(15.9)	6	(20.7)
Not sure	14	(7.4)	2	(6.9)
Discussion with cancer doctor about who would provide follow-up					0.096
Yes	136	(71.6)	18	(62.1)
No	48	(25.3)	11	(37.9)
Not sure	6	(3.2)	0	0.0
Discussion with primary care doctor about who would provide follow-up					0.092
Yes	54	(28.3)	15	(51.7)
No	135	(70.7)	13	(44.8)
Not sure	2	(1.0)	1	(3.4)
Discussion with any other doctor about who would provide follow-up					0.212
Yes	58	(30.5)	8	(27.6)
No	130	(68.4)	20	(69.0)
Not sure	2	(1.1)	1	(3.4)
Discussion with cancer doctor about who would handle care besides cancer					0.039
Yes	46	(24.2)	15	(51.7)
No	142	(74.7)	13	(44.8)
Not sure	2	(1.1)	1	(3.4)
Discussion with primary care doctor about who would handle care besides cancer					0.256
Yes	73	(38.4)	17	(58.6)
No	113	(59.5)	12	(41.4)
Not sure	4	(2.1)	0	0.0
Discussion with any other doctor about who would handle care besides cancer					0.277
Yes	23	(12.0)	8	(27.6)
No	166	(86.9)	21	(72.4)
Not sure	2	(1.0)	0	0.0